The Role of the Hygiene Hypothesis in the Pathogenesis of Type 1 Diabetes
DOI:
https://doi.org/10.54097/w01v4x34Keywords:
The Hygiene hypothesis, Type 1 Diabetes, Autoimmune disease.Abstract
Type 1 diabetes (T1D) is an autoimmune disease where the immune system mistakenly attacks pancreatic β-cells, causing chronic inflammation and inefficient production of insulin due to decreasing βcell number. As insulin production declines, the body cannot maintain glucose homeostasis, leading to diabetes. The incidence of T1D has been rising during the last few years, along with the rapidly developing industrialized world. The hygiene hypothesis could explain this trend by suggesting that exposure to microbes in early ages functions to train the immune system. If the Immune system is highly trained, it is less likely to target self-antigens, reducing the risk of allergies and autoimmune diseases such as T1D. That being said, this review aims to evaluate how the hygiene hypothesis explains the pathogenesis of T1D. The analysis covers the theoretical basis and mechanisms of the hygiene hypothesis, early-life microbial exposures, gut microbiota diversity, environmental and geographical factors, trends in T1D incidence, animal models, and clinical trials. Evidence supports the hygiene hypothesis by highlighting the impact of environmental factors on immune development. However, current research produces contradictory results and often overlooks factors such as genetics, which also influence the onset of T1D. Future research should integrate genetics and other relevant fields with longitudinal data collection to further evaluate and refine the hygiene hypothesis.
Downloads
References
[1] Ikegami, H., Noso, S., Babaya, N., & Kawabata, Y. (2011). Genetics and pathogenesis of type 1 diabetes: prospects for prevention and intervention: Genetics and pathogenesis of type 1 diabetes. Journal of Diabetes Investigation, 2(6), 415–420. https://doi.org/10.1111/j.2040-1124.2011.00176.
[2] Nurminen, N., Cerrone, D., Lehtonen, J., Parajuli, A., Roslund, M., Lönnrot, M., Ilonen, J., Toppari, J., Veijola, R., Knip, M., Rajaniemi, J., Laitinen, O. H., Sinkkonen, A., & Hyöty, H. (2021). Land cover of early-life environment modulates the risk of type 1 diabetes. Diabetes Care, 44 (7), 1506–1514. https://doi.org/10.2337/dc20-1719
[3] Vehik, K., & Dabelea, D. (2012). Why are C-section deliveries linked to childhood type 1 diabetes? Diabetes, 61(1), 36–37. https://doi.org/10.2337/db11-1482
[4] Perkin, M. R., & Strachan, D. P. (2022). The hygiene hypothesis for allergy - conception and evolution. Frontiers in Allergy, 3, 1051368. https://doi.org/10.3389/falgy.2022.1051368
[5] Belkaid, Y., & Hand, T. W. (2014). Role of the microbiota in immunity and inflammation. Cell, 157 (1), 121–141. https://doi.org/10.1016/j.cell.2014.03.011
[6] Meng, X., Layhadi, J. A., Keane, S. T., Cartwright, N. J. K., Durham, S. R., & Shamji, M. H. (2023). Immunological mechanisms of tolerance: Central, peripheral and the role of T and B cells. Asia Pacific Allergy, 13 (4), 175–186. https://doi.org/10.5415/apallergy.0000000000000128
[7] Sakaguchi, S., Yamaguchi, T., Nomura, T., & Ono, M. (2008). Regulatory T cells and immune tolerance. Cell, 133 (5), 775–787. https://doi.org/10.1016/j.cell.2008.05.009
[8] Okada, H., Kuhn, C., Feillet, H., & Bach, J.-F. (2010). The “hygiene hypothesis” for autoimmune and allergic diseases: an update: The ‘hygiene hypothesis’: an update. Clinical and Experimental Immunology, 160 (1), 1–9. https://doi.org/10.1111/j.1365-2249.2010.04139.x
[9] Popoviciu, M. S., Kaka, N., Sethi, Y., Patel, N., Chopra, H., & Cavalu, S. (2023). Type 1 Diabetes Mellitus and autoimmune diseases: A critical review of the association and the application of personalized medicine. Journal of Personalized Medicine, 13 (3). https://doi.org/10.3390/jpm13030422
[10] Ogle, G. D., Wang, F., Haynes, A., Gregory, G. A., King, T. W., Deng, K., Dabelea, D., James, S., Jenkins, A. J., Li, X., Ma, R. C. W., Maahs, D. M., Oram, R. A., Pihoker, C., Svensson, J., Zhou, Z., Magliano, D. J., & Maniam, J. (2025 07). Global type 1 diabetes prevalence, incidence, and mortality estimates 2025: Results from the International diabetes Federation Atlas, 11th Edition, and the T1D Index Version 3.0. Diabetes Research and Clinical Practice, 225. https://doi.org/10.1016/j.diabres.2025.112277
[11] Chapman, N. M., Coppieters, K., von Herrath, M., & Tracy, S. (2012). The microbiology of human hygiene and its impact on type 1 diabetes. Islets, 4 (4), 253–261. https://doi.org/10.4161/isl.21570
[12] Vatanen, T., Franzosa, E. A., Schwager, R., Tripathi, S., Arthur, T. D., Vehik, K., Lernmark, Å., Hagopian, W. A., Rewers, M. J., She, J.-X., Toppari, J., Ziegler, A.-G., Akolkar, B., Krischer, J. P., Stewart, C. J., Ajami, N. J., Petrosino, J. F., Gevers, D., Lähdesmäki, H., … Xavier, R. J. (2018). The human gut microbiome in early-onset type 1 diabetes from the TEDDY study. Nature, 562 (7728), 589–594. https://doi.org/10.1038/s41586-018-0620-2
[13] Hussen, H. I., Moradi, T., & Persson, M. (2015). The risk of type 1 diabetes among offspring of immigrant mothers in relation to the duration of residency in Sweden. Diabetes Care, 38 (5), 934–936. https://doi.org/10.2337/dc14-2348
[14] Vatanen, T., Kostic, A. D., d’Hennezel, E., Siljander, H., Franzosa, E. A., Yassour, M., Kolde, R., Vlamakis, H., Arthur, T. D., Hämäläinen, A.-M., Peet, A., Tillmann, V., Uibo, R., Mokurov, S., Dorshakova, N., Ilonen, J., Virtanen, S. M., Szabo, S. J., Porter, J. A., … Xavier, R. J. (2016). Variation in microbiome LPS immunogenicity contributes to autoimmunity in humans. Cell, 165 (4), 842–853. https://doi.org/10.1016/j.cell.2016.04.007
[15] Wang, X., Yuan, W., Yang, C., Wang, Z., Zhang, J., Xu, D., Sun, X., & Sun, W. (2024). Emerging role of gut microbiota in autoimmune diseases. Frontiers in Immunology, 15, 1365554. https://doi.org/ 10.3389/fimmu.2024.1365554
[16] Cahenzli, J., Köller, Y., Wyss, M., Geuking, M. B., & McCoy, K. D. (2013). Intestinal microbial diversity during early-life colonization shapes long-term IgE levels. Cell Host & Microbe, 14 (5), 559–570. https://doi.org/10.1016/j.chom.2013.10.004
[17] Reynolds, H. M., & Bettini, M. L. (2023). Early-life microbiota-immune homeostasis. Frontiers in Immunology, 14, 1266876. https://doi.org/10.3389/fimmu.2023.1266876
[18] Olszak, T., An, D., Zeissig, S., Vera, M. P., Richter, J., Franke, A., Glickman, J. N., Siebert, R., Baron, R. M., Kasper, D. L., & Blumberg, R. S. (2012). Microbial exposure during early life has persistent effects on natural killer T cell function. Science (New York, N.Y.), 336 (6080), 489–493. https://doi.org/ 10.1126/science.1219328
[19] Bonifacio, E., Ziegler, A.-G., Klingensmith, G., Schober, E., Bingley, P. J., Rottenkolber, M., Theil, A., Eugster, A., Puff, R., Peplow, C., Buettner, F., Lange, K., Hasford, J., Achenbach, P., & Pre-POINT Study Group. (2015). Effects of high-dose oral insulin on immune responses in children at high risk for type 1 diabetes: the Pre-POINT randomized clinical trial: The pre-POINT randomized clinical trial. JAMA: The Journal of the American Medical Association, 313 (15), 1541–1549. https://doi.org/10.1001/jama. 2015.2928
[20] Bach, J.-F. (2002). The effect of infections on susceptibility to autoimmune and allergic diseases. The New England Journal of Medicine, 347 (12), 911–920. https://doi.org/10.1056/NEJMra020100
[21] Stene, L. C., Magnus, P., Lie, R. T., Søvik, O., Joner, G., & Norwegian Childhood Diabetes Study Group. (2003). No association between preeclampsia or cesarean section and incidence of type 1 diabetes among children: a large, population-based cohort study. Pediatric Research, 54 (4), 487–490. https://doi.org/ 10.1203/01.PDR.0000081301.25600.5D
Downloads
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
